MA46437A - Agonistes de ppar, composés, compositions pharmaceutiques, et procédés d'utilisation de ceux-ci. - Google Patents
Agonistes de ppar, composés, compositions pharmaceutiques, et procédés d'utilisation de ceux-ci.Info
- Publication number
- MA46437A MA46437A MA046437A MA46437A MA46437A MA 46437 A MA46437 A MA 46437A MA 046437 A MA046437 A MA 046437A MA 46437 A MA46437 A MA 46437A MA 46437 A MA46437 A MA 46437A
- Authority
- MA
- Morocco
- Prior art keywords
- compounds
- methods
- pharmaceutical compositions
- ppar agonists
- ppar
- Prior art date
Links
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562238629P | 2015-10-07 | 2015-10-07 | |
| PCT/US2016/055521 WO2017062468A1 (fr) | 2015-10-07 | 2016-10-05 | Agonistes de ppar, composés, compositions pharmaceutiques et méthodes d'utilisation de ceux-ci |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA46437A true MA46437A (fr) | 2021-04-21 |
| MA46437B1 MA46437B1 (fr) | 2022-03-31 |
Family
ID=61158553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA46437A MA46437B1 (fr) | 2015-10-07 | 2016-10-05 | Agonistes de ppar, composés, compositions pharmaceutiques, et procédés d'utilisation de ceux-ci. |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR106298A1 (fr) |
| MA (1) | MA46437B1 (fr) |
-
2016
- 2016-10-05 MA MA46437A patent/MA46437B1/fr unknown
- 2016-10-07 AR ARP160103079A patent/AR106298A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA46437B1 (fr) | 2022-03-31 |
| AR106298A1 (es) | 2018-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52098A (fr) | Agonistes de ppar, composés, compositions pharmaceutiques et leurs procédés d'utilisation | |
| EP3665156A4 (fr) | Composés, compositions et procédés | |
| EP3313404A4 (fr) | Compositions thérapeutiques, associations et procédés d'utilisation | |
| EP3676297A4 (fr) | Composés, compositions et procédés | |
| EP3316894A4 (fr) | Composés et compositions comprenant des oligodésoxynucléotides phosphorothioés, et procédés d'utilisation associés | |
| EP3380101A4 (fr) | Composés inhibiteurs d'eif4-a et procédés associés | |
| MA48797A (fr) | Variants de l'endonucléase cblb , compositions et procédés d'utilisation | |
| MA48942A (fr) | Composés thérapeutiques, compositions et procédés d'utilisation associés | |
| EP3340988A4 (fr) | Composés inhibiteurs de canaux ioniques, formulations pharmaceutiques, et utilisations | |
| EP3364984A4 (fr) | Composés et compositions comprenant des oligodésoxynucléotides phosphorothioés, et procédés d'utilisation associés | |
| MA39915B1 (fr) | Composés de pladiénolide pyridine et leurs procédés d'utilisation | |
| EP3845528A4 (fr) | Composés de pyrazole, compositions pharmaceutiques correspondantes et utilisation associées | |
| EP3496768A4 (fr) | Compositions antimicrobiennes et procédés d'utilisation associés. | |
| MA42527A (fr) | Agonistes de récepteur 5-ht2c et compositions et procédés d'utilisation | |
| MA46059A (fr) | Variants de l'endonucléase homing tim3, compositions et procédés d'utilisation | |
| MA45987A (fr) | Agonistes des récepteurs 5-ht2c, compositions et méthodes d'utilisation | |
| EP3383853A4 (fr) | Dérivés d'homobispypéridinyle en tant qu'agonistes des oxystérols bêta, compositions et leur utilisation | |
| MA46543A (fr) | Variants de l'endonucléase tgfbéta r2, compositions et procédés d'utilisation | |
| EP3334719A4 (fr) | Benzimidazoles substitués, préparation et utilisation de ceux-ci en tant qu'agents pharmaceutiques | |
| EP3468555A4 (fr) | Composés antimicrobiens et leurs procédés d'utilisation | |
| MA40781A (fr) | Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale | |
| EP3347003A4 (fr) | Composés de thréonate et leurs procédés d'utilisation | |
| MA43848A (fr) | Composés deutérés pour le traitement d'hémopathies malignes, compositions et procédés associés | |
| EP3717475A4 (fr) | Composés inhibiteurs de kinase, compositions et procédés d'utilisation | |
| EP3280271A4 (fr) | Compositions d'aliment pour animaux et procédés d'utilisation |